Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

Heikki Joensuu, Peter J. Roberts, Maarit Sarlomo-Rikala, Leif C. Andersson, Pekka Tervahartiala, David Tuveson, Sandra L. Silberman, Renaud Capdeville, Sasa Dimitrijevic, Brian Druker, George D. Demetri

Research output: Contribution to journalArticle

1733 Scopus citations
Original languageEnglish (US)
Pages (from-to)1052-1056
Number of pages5
JournalNew England Journal of Medicine
Volume344
Issue number14
DOIs
StatePublished - Apr 5 2001

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Joensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S. L., Capdeville, R., Dimitrijevic, S., Druker, B., & Demetri, G. D. (2001). Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. New England Journal of Medicine, 344(14), 1052-1056. https://doi.org/10.1056/NEJM200104053441404